Abnova Taiwan Corp
TWSE:4133
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Abnova Taiwan Corp
TWSE:4133
|
TW |
|
I
|
IBI-Lion SOCIMI SA
MAD:YIBI
|
ES |
|
AnaptysBio Inc
NASDAQ:ANAB
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Abnova Taiwan Corp's stock price target?
Not Available
Abnova Taiwan Corp doesn't have any price targets made by Wall Street professionals.
What is Abnova Taiwan Corp's Revenue forecast?
Projected CAGR
5%
For the last 14 years the
compound annual growth rate for
Abnova Taiwan Corp's revenue is
-2%.
The projected
CAGR
for the next 8 years is
5%.
What is Abnova Taiwan Corp's Operating Income forecast?
Projected CAGR
19%
For the last 14 years the
compound annual growth rate for
Abnova Taiwan Corp's operating income is
-13%.
The projected
CAGR
for the next 8 years is
19%.